Navigation Links
Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication
Date:12/29/2010

ing, and eliminating corticosteroid use in patients with moderately to severely active UC who have had an inadequate response to conventional therapy.
  • Reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage and improving physical function in patients with PsA.  
  • Treatment of adult patients with chronic severe plaque PsO who are candidates for systemic therapy and when other systemic therapies are medically less appropriate.

  • REMICADE is unique among available anti-TNF biologic therapies.  It is the only anti-TNF biologic administered directly by caregivers in the clinic or office setting.  REMICADE is a two-hour infusion administered every 4 or 8 weeks (indication-dependent), following a standard induction regimen that requires treatment at weeks 0, 2 and 6.  As a result, REMICADE patients may require as few as six treatments each year as maintenance therapy.

    Centocor Ortho Biotech Inc. discovered and developed REMICADE and has exclusive marketing rights to the product in the United States.  

    Important Safety Information  

    Only a doctor can recommend a course of treatment after checking a patient's health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. There are reports of serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.

    Unusual cancers have been reported in children and teenage patients taking TNF-blocker medicines. A rare form of fatal lymphoma has occurred mostly in teenage or young adult males with Crohn's disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine.
    '/>"/>

    SOURCE Centocor Ortho Biotech Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
    2. Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotechs New Psoriasis Agent Stelara (ustekinumab) is High
    3. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI® Label to Include Inhibition of Structural Damage in Treatment of Psoriatic Arthritis
    4. Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer
    5. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
    6. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
    7. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
    8. Clinical Data Presented on OrthoGlide(R) Medial Knee Implant
    9. ORTHO EVRA(R) Prescribing Information Updated
    10. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
    11. Data From Ortho Biotech-Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... ANGELES , Jan. 23, 2015 A lot of ... best methods for treating  certain illnesses, injuries, or conditions. As ... replace previous treatment methods with ones that they consider to ... hernias, there is not one textbook method of treatment that ...
    (Date:1/23/2015)... ( www.medscope.org ), the leading provider of medical alert ... World magazine Connected World Award for its new ... used anywhere, anytime. The nomination was made by RacoWireless, ... MedScope, Landon Garner , Director of Marketing of ...
    (Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
    Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
    ... HHS, Agency for Healthcare Research and Quality today ... contracts to support projects that will help people make ... effectiveness. The funding announced today covers all of AHRQ,s ... by AHRQ.   The projects will support ...
    ... Healthpoint today announced that the results of a new ... will be presented on Thursday, September 30, 2010 at 7:15pm ... Clinical Symposium on Advances in Skin & Wound Care: The ... from September 30 to October 3, 2010, at the Gaylord ...
    Cached Medicine Technology:HHS Awards $473 Million in Patient-Centered Outcomes Research Funding 2New Study Reveals Collagenase SANTYL® Ointment More Effective Than Hydrogel Dressing for Pressure Ulcer Debridement 2New Study Reveals Collagenase SANTYL® Ointment More Effective Than Hydrogel Dressing for Pressure Ulcer Debridement 3New Study Reveals Collagenase SANTYL® Ointment More Effective Than Hydrogel Dressing for Pressure Ulcer Debridement 4
    (Date:1/22/2015)... with its top dressmaking technologies, has been a leading dress ... its latest designs of wedding dresses and launching a site-wide ... all the fresh new products are designed for 2015, and ... off. All the clothes from LunaDress follow up with the ...
    (Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
    (Date:1/22/2015)... York (PRWEB) January 22, 2015 The federal ... in the U.S. District Court, Southern District of West Virginia ... Inc. in that proceeding’s first bellwether trial. In an Order ... a new trial after finding that C.R. Bard had not ...
    (Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz ... has treated just about every type of injury that can result ... those same twenty-plus years, the team at Doctors on Liens ... best possible doctor. With the combined breadth of experience ...
    (Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
    Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
    ... Inc., a leader in the discovery and development of ... and autoimmune diseases, today announced the appointment of John ... Chief Executive Officer. Dr. Scarlett brings nearly 30 ... his new role. Susan Molineaux, Ph.D., who founded ...
    ... in on the future of SBIR grants in Washington, DC as a ... grants being explicitly excluded from NIH stimulus money. Federal reauthorization or a ... ... February 25, 2009 -- Looking for funding for small business ...
    ... the first time in Asia, the,healthcare and hospital ... gain,leading-edge business insight and first-hand access to innovative ... , Dedicated to the ... designing, building, operating, managing and refurbishing community,in the ...
    ... off antidepressants, antipsychotics, benzodiazepines and ADHD Medication without withdrawal side. The ... by James Harper, researcher and founder of The Road Back Program, ... separate chapters covering each of several classes of drugs. , ... ...
    ... Action on Health Care Reform, But Majority Think It ... on Health Reform is HighMENLO PARK, Calif., Feb. 25 ... is increasingly worried about the affordability and availability of ... cost in the past year and a notable minority ...
    ... Anna Burger Statement on President Obama,s address to CongressWASHINGTON, ... Anna Burger issued the following statement ... "Tonight, I was reminded of why working men and ... November for Barack Obama. President Obama demonstrated vision, courage ...
    Cached Medicine News:Health News:Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO 2Health News:Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO 3Health News:The Commercialization Funding Coach, Fred Patterson, Weighs In On SBIR Funding for Small Business Ventures in Wake of NIH Exclusion 2Health News:The Commercialization Funding Coach, Fred Patterson, Weighs In On SBIR Funding for Small Business Ventures in Wake of NIH Exclusion 3Health News:Hospital Build Asia Exhibition and Congress 2009: Region's Most Comprehensive Healthcare Infrastructure Planning and Development Event to Debut in Singapore 2Health News:Hospital Build Asia Exhibition and Congress 2009: Region's Most Comprehensive Healthcare Infrastructure Planning and Development Event to Debut in Singapore 3Health News:How to Get Off Psychiatric Drugs Safely 2Health News:More Than Half of Americans Say Family Skimped on Medical Care Because of Cost in Past Year; Worries About Affordability and Availability of Care Rise 2Health News:More Than Half of Americans Say Family Skimped on Medical Care Because of Cost in Past Year; Worries About Affordability and Availability of Care Rise 3Health News:More Than Half of Americans Say Family Skimped on Medical Care Because of Cost in Past Year; Worries About Affordability and Availability of Care Rise 4Health News:More Than Half of Americans Say Family Skimped on Medical Care Because of Cost in Past Year; Worries About Affordability and Availability of Care Rise 5Health News:'The Bold Leadership America Needs to Confront a Broken Healthcare System' 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: